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The role of open and endovascular treatment with
fenestrated and chimney endografts for patients
with juxtarenal aortic aneurysms
Konstantinos P. Donas, MD, PhD,a Markus Eisenack, MS,a Giuseppe Panuccio, MD, PhD,a
Martin Austermann, MD, PhD,a Nani Osada, PhD,b and Giovanni Torsello, MD, PhD,a Münster, Germany
Objective: To present endovascular techniques in the treatment of juxtarenal aortic aneurysms (JAAAs) in relation to
surgical repair; this is the “gold standard.”
Methods: Between January 2008 and December 2010, 90 consecutive patients were diagnosed with primary degenerative
JAAAs (>5.0 cm) and assigned prospectively to different operative strategies on the basis of morphologic and clinical
characteristics. In particular, 59 patients were treated by endovascular means such as fenestrated endovascular abdominal
aortic repair (f-EVAR, n  29) or chimney endovascular abdominal aortic repair (ch-EVAR, n  30) endografting, and
31 patients underwent open repair (OR, n  31).
Results: Early procedure-related and all-cause (30-day) procedure-related mortality was 0% for the endovascular group
and 6.4% (n  2/31) for the OR group, due to systemic inflammatory response syndrome with consecutive multi-organ
failure (P .023). Persistent postoperative hemodialysis occurred only after OR (2/31; 6.4%). The overall estimated pre-
and postoperative median estimated glomerular filtration rate and creatinine values were similar in the three subgroups.
There was one left renal artery occlusion for each endovascular subgroup, which presented as flank pain and was treated
by iliaco-renal bypass in both cases. Transfusion requirements and length of hospital stay were significantly less in the
endovascular group (P  .014 and P  .004, respectively).
Conclusions: Endovascular treatment of JAAA is a safe alternative for the short-term management of JAAA. (J Vasc Surg
2012;56:285-90.)
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tSurgery of juxtarenal aortic aneurysms (JAAAs) is a
well-established treatment modality and reflects the “gold
standard.” The overall 30-day mortality in the open series
has been reported as 3.6% in a systematic review of the
literature.1 However, the published reports are inhomoge-
neous, creating questions whether these cohorts are truly
representative for the vascular surgical community. Surgery
is associated with early and late complications such as
myocardial infarction, impaired renal function, and abdom-
inal wall hernias or small bowel obstruction.2-5
Endovascular means may offer alternative less invasive
procedures especially for patients with JAAAs and severe
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owever, the main concern remains the insufficient neck
nd inadequate sealing of the endografts. Several tech-
iques have been proposed to ensure secure proximal fixa-
ion to increase the applicability of endovascular abdominal
ortic repair (EVAR).
The chimney graft technique (ch-EVAR) is based on
he deployment of a covered or bare-metal stent parallel to
he aortic endograft, thereby creating a conduit that runs
utside the aortic main endograft, to retain or rescue blood
ow into overstented aortic branches along the sealing
ones in a totally endovascular way. The published experi-
nce with this minimally invasive aortic branch preservation
echnique is somewhat promising6-8; however, no robust
onclusion can be drawn due to small series and case reports
nd limited short-term follow-up.6-8
The other endovascular approach for JAAA is fenes-
rated endografting. The Zenith (Cook, Brisbane, Austra-
ia) fenestrated stent graft has been developed and can be
ustom manufactured based on individual patient aneu-
ysm and renal vessel morphology.9-11 It is a Conformité
uropéenne (CE)-marked product with the corresponding
reclinical and clinical testing. However, use and applica-
ion of those stent grafts require advanced technical skills
nd radiologic imaging. This limitation makes the alterna-
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August 2012286 Donas et altive endovascular treatment, even if large cohorts with mid-
and long-term results are already published, possible only
in highly specialized volume centers.
The present article demonstrates a direct comparison
of the largest single-center series in the literature of
patients with JAAAs treated with endovascular tech-
niques such as fenestrated endovascular abdominal aortic
repair (f-EVAR) and ch-EVAR vs the “gold standard”
open repair (OR).
METHODS
Treatment algorithm for JAAAs. Since 2009, we
established an algorithm for managing JAAAs, which is
shown in Fig 1. Patients who were deemed physiologically
fit and young (68 years) underwent conventional OR.
Another indication for surgical approach was the case of
coexistence of accessory polar renal arteries with evidence
of significant kidney perfusion by scintigraphy; surgical
approach was also preferred. A patient needed to qualify for
at least one of the inclusion criteria to get selected for open
repair. Patients were classified as high-risk for surgical repair
in case of serious cardiovascular comorbidities (more than
three; such as chronic obstructive lung disease, congestive
heart failure, and coronary artery occlusive disease; Ameri-
can Society of Anesthesiologists [ASA] score of three or
more; previous myocardial infarction; coronary stent or
bypass; redo cases [abdominal and/or iliac aortic repair]).
High-risk patients underwent endovascular repair. In de-
tail, symptomatic JAAAs or aneurysms with rapid eccentric
growth (0.5 cm/annually) were treated by the chimney
technique. All patients treated by chimneys had at least
15-mmneck distance between the target vessel (renal artery
and occasionally superior mesenteric artery) for the chim-
ney grafts and the upper aortic branch (either superior
mesenteric artery or celiac trunk), patent left subclavian
Acceptable risk for open repair 
Young patient (< 68 y)       yes open repair
Accessory polar renal arteries  
No  
EVAR 
symptomatic or rapid eccentric growth (>0.5 cm/annually),  yes          Chimney
presence of at least 15mm neck distance  
between the target vessel and the lower upper aortic side branch,  
patent left subclavian artery,  
absence of severe kinking of the descending aorta  
or extensive thrombus in the aortic arch and juxtarenal segment, 
involvement of less than 2 aortic side branches 
No  
f-EVAR 
Fig 1. Treatment algorithm of patients with juxtarenal aortic aneu-
rysms (JAAAs). EVAR, Endovascular aneurysm repair, f-EVAR, fe-
nestrated endovascular aneurysm repair.artery, absence of severe kinking of the descending aorta, or (xtensive thrombus in the aortic arch and juxtarenal seg-
ent. Finally, downward direction of the target vessels was
lso important to facilitate easy cannulation through a
rachial approach.
We performed f-EVAR in case of involvement of more
han two branches in the aneurysm. The reasons were
etter fixation of the endograft by f-EVAR and additional
voidance of narrowing of the aortic lumen by implantation
f more than two chimney grafts. Thus, in case of a pro-
ressive degeneration of the aorta, above the bridging
tents of the aortic side branches, a repair of f-EVAR is
asier and safer, compared with multiple (2) chimneys.
oreover, we used fenestrated endografts in case of insuf-
cient neck between the lower and upper branches (15
m) and upper channel of the target vessels, and also in
ase of large (at least 2F or 8.6-mm diameter of the access
essels).
The mean follow-up of OR, chimney, and f-EVAR
ubgroups was 14.1  7.1, 15.2  6.2, and 13.2  4.2
onths, respectively.
Preoperative investigations. All patients underwent
contrast-enhanced computed tomography angiography
CTA) of the abdomen and pelvis. The CTAwas performed
o study aortic pathology and to delineate visceral and renal
orphology and iliofemoral anatomy.
Definitions. We describe as primary degenerative
AAA a complex abdominal aortic aneurysm with a short
nfrarenal neck (9 mm) or aneurysmal extension to the
nter-renal aorta. The inadequate landing zone for the graft
elow the renal vessels precludes conventional EVAR and,
n case of open repair, a suprarenal aortic clamping is
ecessary. Patients with persistent type I endoleaks after
onventional EVAR, proximal para-anastomotic pseudo-
neurysms after OR, or ruptured, mycotic, or inflammatory
AAAs were excluded.
The primary composite end points were 30-day mor-
ality and deterioration of renal function measured by esti-
ated glomerular filtration rate (eGFR), serum creatinine,
nd permanent dialysis dependence. Additionally, blood
oss, transfusion requirements and length of stay (LOS),
arget vessel patency, and reinterventions were noted as
econdary end points.
eGFR was calculated using the Chronic Kidney Disease
pidemiology Collaboration (CKD-EPI) formula, which
etter estimates GFR above 30 mL/min/1.73 m2 than
ther formulas. Deterioration of renal function was defined
s a doubling of creatinine or50% decline in eGFR. Renal
ailure was defined as a threefold increase in creatinine, a
75% decline in renal function, or a serum creatinine of4
g/dL with an acute rise of 0.5 mg/dL. Renal function
as determined by comparing the baseline value and the
ostoperative laboratory value.
EVAR with chimney technique. All procedures were
erformed in a hybrid operating room under fluoroscopic
ontrol (Axiom Artis FA; Siemens Medical Solutions,
orchheim, Germany) with a totally percutaneous ap-
roach using the Prostar XL 10F vascular closure device
Abbott Vascular, Abbott, Park, Ill). The chimney grafts
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Volume 56, Number 2 Donas et al 287were advanced in the renovisceral aortic segment via an
open or percutaneous brachial approach and use of a 6F or
7F shuttle sheath (Cook, Bloomington, Ind). The target
vessels (renal arteries or superior mesenteric artery [SMA])
were cannulated with a 5F catheter (Angiodynamics Inc,
Quensburry, NY) and the Rosen wire (Infiniti Medical,
Malibu, Calif) sheath was placed into the target vessel. At
least one Advanta balloon-expandable stent graft (Atrium,
Hudson, NH) was used as chimney graft to preserve flow to
the overstented renal artery and synchronously extend the
proximal fixation zone for the aortic stent graft in all cases.
The deployment of the chimney stent followed the deploy-
ment of the main abdominal stent graft.
Fenestrated endovascular aortic aneurysm repair.
Preoperative diagnostic measurements were performed by
using the TeraRecon Aquarius software (TeraRecon Inc,
San Mateo, Calif). In all patients, a custom-made Zenith
fenestrated graft was used (Cook Medical Inc, Blooming-
ton, Ind). f-EVAR procedures were carried out under
general or loco-regional anesthesia in an endovascular suite
equippedwith AxiomArtis FA (SiemensMedical Solutions,
Forchheim, Germany) imaging system.
The fenestrated endograft procedure is well de-
scribed.10 Since 2009, the standard fenestrated device in
our institution had two fenestrations for the renal ostia and
a scallop in the covered stent to incorporate the SMA
origin.
Open surgical repair. For exposure of JAAAs, a lon-
gitudinal laparotomy was used. The superior mesenteric
artery and celiac axis were occasionally exposed by excising
the dense autonomic ganglia on the left lateral surface of
the aorta and by incising the left crus of the diaphragm only
in case of insufficient suprarenal clamping and need for
supravisceral clamping. We used Dacron as prosthetic graft.
The patients underwent general anesthesia alone (n  13)
or with additional peridural anesthesia (n  14).
Follow-up protocol included physical examination and
abdominal duplex ultrasound at 3 and 6months. Cabdomi-
nal duplex ultrasoundTA and plain X-ray of the device in
Table I. Demographics and comorbidities in patients with
Ch-E
Age, years 74.5
Men 27
Size of the aneurysm, cm 6
Creatinine (mg/dL, mean  SD) 1.2
eGFR (mL/min/1.73 m2, mean  SD) 64.5
Comorbidities
Cardiac 22
Renal (creatinine 100 mg/mL) 7
Respiratory 10
Previous aortic intervention 11
Previous aortocoronary bypass or intervention 10
Previous myocardial infarction 9
ch-EVAR,Chimney endovascular abdominal aortic repair; f-EVAR, fenestrat
open repair.two projections were additionally performed after endovas- eular treatment prior to hospital discharge, at 1 year, and
early thereafter. All secondary graft-related procedures
erformed in the perioperative period and during the fol-
ow-up time were described and analyzed. Secondary pro-
edures included all reinterventions performed due to tech-
ical problems related to the graft or to the ancillary
omponents (endoleak, migration, limb graft stenosis/
hrombosis, stent fracture, stent dislocation, in-stent steno-
is/occlusion).
Statistical analysis was performed by means of SPSS
5.0 for Windows (SPSS Inc, Chicago, Ill). The Student t-
nd 2 tests were employed for statistical analysis of nor-
ally distributed variables; nonparametric data were ana-
yzed with the Wilcoxon rank-sum test. Results in renal
unction were calculated as mean  standard deviation or
edian (interquartile range [IQR]). Long-term results in
erms of freedom from migration/type I endoleak, and
reedom from any device-related secondary procedures,
ere assessed with Kaplan-Meyer curves.
Continuous variables were compared using a Student
-test and Wilcoxon Mann-Whitney test, and categorical
ariables compared with Fisher exact test.
ESULTS
Between January 2008 and December 2010, 59 pa-
ients were treated by endovascular means such as fenes-
rated (f-EVAR, n  29) or chimney (ch-EVAR, n  30;
even patients with symptomatic aneurysms) endograft-
ng, and 31 patients underwent OR. Demographic and
natomical data are shown in Table I. A comparison of
utcomes of the three groups is presented in Table II.
o evidence of type I or III occurred perioperatively.
he success rate for target vessel preservation was 97.4%
or the ch-EVAR and 97.7% for the f-EVAR groups (Fig
). There were three type II endoleaks diagnosed on
-month postoperative computed tomography scans,
ne in f-EVAR and two in ch-EVAR, but no type I or III
As treated by open or endovascular repair
f-EVAR OR P
73.7  6.1 71.2  7.8 2.2
29/29 27/31 1.34
6.5 6.0 2.4
1.2  0.2 1.1  1.4 2.1
63.5  29 69  99 1.1
24 9 .45
5 2 .56
11 6 .55
8 2 .34
12 2 .03
7 0 .36
ovascular abdominal aortic repair; JAAAs, juxtarenal aortic aneurysms;OR,JAA
VAR
 7.3
/30
.2
 0.8
 27
ed endndoleaks.
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the chimney grafts subgroup, no new occlusion of chimney
graft or occurrence of type I endoleak was noted.
Mortality. Thirty-day procedure-related mortality was
0% for the endovascular group and 6.4% (n  2/31) for
the OR group, respectively (P .023). Both patients
developed, in the second postoperative day, systemic
Table II. Procedure details and 30-day outcomes for patie
Ch-EV
Target vessel preservation 97.4
Operation duration, minutes 89 
Contrast medium (mL) 112 
Fluoroscopic time, minutes 44.8 
Renal artery chimney 35/3
Bilateral 5
Right 19
Left 16
SMA chimney 3
Types of chimney stent
- Covered balloon expandable (Advanta) 38/3
f-EVAR bridging stent
- Covered balloon expandable (Advanta)
- Bare balloon expandable (Palmaz)
Endoleak
Type I 0
Type II 2
Mortality 0
ch-EVAR,Chimney endovascular abdominal aortic repair; f-EVAR, fenestrat
open repair; SMA, superior mesenteric artery.
Fig 2. Bridging stent pateinflammatory response syndrome with consecutive mul- 3iorgan failure. The median suprarenal cross-clamp time
n these two cases was 23.2 minutes. The mean duration
f the operation for these two patients was 3.4 hours.
Morbidity. Transfusion requirements and LOS were
ignificantly less for the endovascular group (P  .014 and
 .004, respectively). In particular, 3.2 1.2 transfusion
nits of the open group vs 0.2 of the endo-group and 7.2
ith JAAAs treated by open or endovascular repair
f-EVAR OR P
97.7% — .56
290  122 — .04
156  56 — .23
54.3  12.2 — .34
32/44
12/44
0
1
0 2 .023
ovascular abdominal aortic repair; JAAAs, juxtarenal aortic aneurysms;OR,
r the endovascular group.nts w
AR
%
21
23
13.2
8
8
ed end.2 days of hospital stay in the open group vs 3.5  1.1 of
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more common after OR (2/31) vs 0/59 for the endovas-
cular group. The overall estimated pre- and postoperative
median eGFR in the endovascular group was 64  28
mL/min/1.73m2 and 69 31mL/min/1.73m2 vs 69
99 mL/min/1.73 m2 and 58  33 mL/min/1.73 m2 of
the OR group (P  .3 vs P  .025), respectively. The
median pre- and postoperative creatinine values were 1.2
0.4 mg/dL and 1.1  5.4 mg/dL of the endo-group vs
1.1 1.4 mg/dL and 1.4 8.3 mg/dL of the OR group,
(P  .1 and P  .021), respectively.
From theOR group, one patient had perioperative pneu-
monia treated by antibiosis. Another patient experienced a
minor stroke with complete recovery by time of discharge.
Adjuvant procedures and reinterventions. In partic-
ular, 38 chimney grafts and 44 bridging stents in the
f-EVAR group were placed. All chimney grafts were Ad-
vanta covered stents. Thirty-five stents were placed in the
renal arteries and three in the superior mesenteric artery. In
the f-EVAR group, 32 Advanta stents and 12 Palmaz
(Cordis, Miami Lakes, Fla) bare stents were used as bridg-
ing devices. There was one left renal artery occlusion for
each endovascular subgroup treated by iliaco-renal Dacron
bypass in both endovascular cases. The patient of the ch-
EVAR group suffered from left flank pain 45 days postop-
eratively. The chimney graft to a left renal artery (Advanta,
6  59 mm) was occluded. The patient underwent open
thrombectomy of the left renal artery and placement of
8-mm Dacron iliorenal bypass. Postoperatively, the patient
suffered a myocardial infarction, but urgent coronary an-
giography showed good collateralization, so no further
intervention was needed. The patient recovered complete-
ly; resting renal scintigraphy showed 36% perfusion for the
left side and 64% for the right side. Creatinine value in-
creased to 1.6 mg/dL from 0.9 mg/dL.
In the f-EVAR group, one symptomatic left renal artery
occlusion was also recorded 6 months postoperatively. The
bridging stent was an Advanta, 6  22 mm. The patient
underwent open thrombectomy of the left renal artery and
placement of 8-mm Dacron iliorenal bypass. Postopera-
tively, the patient had an uneventful course. Creatinine
value increased to 1.5 mg/dL from 0.8 mg/dL without
need for dialysis. Additionally, one reintervention was nec-
essary in the f-EVAR group due to a symptomatic restenosis
of the superior mesenteric artery with abdominal pain and
elevation of lactate values (4.3 mmol/L) treated by addi-
tional stent placement (6  60 mm, ev3; ev3 Inc, Irvine,
Calif). The further course was uneventful.
For the OR group, one patient with peripheral arterial
disease suffered perioperatively from an acute occlusion of
the left popliteal artery and rest pain (Rutherford IV)
treated by popliteal vein bypass grafting.
DISCUSSION
The present prospective study demonstrates for the first
time in the literature that short-term endovascular treat-
ment of JAAA is safe and offers a lower risk, less-invasive
alternative for the management of JAAA. These are the cargest endovascular series and also the first attempt in the
iterature as a single center report to present two endovas-
ular techniques for patients with JAAAs in relation to the
gold standard” OR. Early mortality, blood loss, LOS, and
cute kidney injury were significantly less in the endovascu-
ar group than in patients undergoing OR. Our study
emonstrates safety and feasibility of endovascular tech-
iques in complex abdominal aneurysms where an infrare-
al neck is too short or not available at all.
The current literature provides limited evidence re-
arding the role of endovascular techniques in the treat-
ent of JAAAs. The absence of a clear stratified classifica-
ion system for JAAAs, the possible publication bias of the
eporting series of different centers, and the often hetero-
eneous pathologies treated (including both primary and
esidual aneurysms, pseudoaneurysms) highlight remark-
ble limitations when attempting to compare the outcome
f OR vs endovascular repair of this type of pathology.
The fenestrated technique has been popularized by
any centers and is merely a means to fully utilize the
nfra-renal sealing area without jeopardizing the branching
essels. A recent systematic literature review1 showed that
elective f-EVAR appears to have reduced perioperative
ortality compared with OR. However, the relatively short
ollow-up and the highly selective series are limitations of
he review analysis.1
In contrast to f-EVAR, chimney grafts are positioned
long the outside of the main abdominal endografts and
ely on the close conformation of the endograft and the
ortic wall around the chimney stent. ch-EVARmay extend
he anatomical eligibility of endovascular aneurysm repair
sing conventional devices. However, the reported cases in
he literature are also very limited and do not allow us to
raw robust conclusions about the use of this alternative
echnique.6,7 There is only one comparative matched anal-
sis in the literature that compared the early outcomes of
ndovascular repair of JAAA using the chimney technique
ith OR in anatomically matched patients.8 It appears to
ave similar mortality to OR with less morbidity.
In particular, the chimney technique is feasible in combi-
ation with all standard abdominal devices. Especially, in our
h-EVAR group, flexible devices of low profile such as the
ndurant stent graft (Medtronic Vascular, Santa Rosa, Calif)
erformed very well in combination with balloon expandable
overed stents. No patient experienced early or midterm (24
onths) type I or III endoleak. ch-EVAR is also applicable in
atients with small external iliacs with diameter of 6 mm or in
ortuous anatomies. The treatment is possible also in case of
ymptomatic aneurysms with the need for emergent ap-
roach. The technique is easy for physicians with expertise in
onventional EVAR and is reproducible. Based on our data,
he fluoroscopy time of chimneys is less than that of f-EVAR.9
On the other hand, the mechanism of a seal around the
himney stents, so-called “gutters” around the chimney
rafts, may determine the degree of conformation of the
ndograft around the chimney stent. There is a hypothesis
hat the rigidity of the aortic wall, especially in case of high
alcification, may provoke type I endoleak. Resistance to flow
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the longer the length of the gutter, the greater the chance for
spontaneous thrombosis of the flow channel. We used in all
cases a covered balloon expandable stent providing high radial
force and excellent seal. The midterm patency was 97.4%. We
recorded only one occlusion, treated by surgical conversion
through retroperitoneal exposure. It seems that the radial
force of balloon expandable covered stents is sufficient, and no
placement of supplementary stents is necessary, thereby avoid-
ing a lot of devices in a very small region. This is an important
issue because in case of disease progression because of aortic
degeneration and occlusion of the chimney grafts, this high-
risk patient population would be more difficult to salvage
without open surgery. Limitation of ch-EVAR is the need of
brachial access. A total femoral approach is not possible as
routine access.
Alternative treatment options include fenestrated en-
dografts. Standard devices with two fenestrations and one
scallop for the SMA allow excellent apposition in the arterial
wall and fixation of the endograft. The procedure can be
performed by femoral access alone without need of brachial
approach. Secondary procedures by less invasive endovascular
means are possible.10 Fenestrated devices are not yet currently
readily available. Production time of these custom devices is
also an issue due to possible interval rupture of aneurysms
from the time of evaluation and availability of the devices.
We recorded excellent branch vessel patency of 97.7%
having one occlusion of a renal artery with need for open
conversion and explantation of the occluded bridging
stent. We used, in the majority of the branches, balloon
expandable covered stents (32/44, 72.7%). Qureshi11
published recently an overview of the current literature
regarding total endovascular repair of JAAAs. Our results
are slightly superior compared with the current literature,
which shows branch vessel patency between 89.4% and
92.2%.11
Another important issue in the treatment of JAAAs
remains the “renal side of the story.” The avoidance of
suprarenal clamping and ischemia may explain the excellent
results of the endovascular arm. The short-term mean
endovascular postoperative eGFR and creatinine values
were significantly inferior compared with those of the sur-
gical approach. Additionally, two patients (all of the OR
group) vs none from the endovascular group suffered from
persistent postoperative dialysis. Based on these results, it
seems that application of contrast medium during ch-
EVAR and f-EVAR does not influence the outcome at least
for the short-term.
Limitations of f-EVAR are the need for at least 22F or
8.6-mm diameter of the access vessels. Another drawback
of the fenestrated grafts is that they need a production time
of 6 to 8 weeks. Finally, the procedure is technically de-
manding and time-consuming, requiring advanced endo-
vascular experience and skills and profound planning.
In summary, endovascular repair of JAAAs remains an
evolving area in vascular surgery. The current study showed
that both ch-EVAR and f-EVAR are technically feasible
with successful exclusion of the aneurysm and can be per- Sormed with low morbidity and mortality in a cohort of
atients deemed unfit for OR. To our knowledge, this has
ever been systematically studied or reported as a single
enter analysis. Long-term durability, including preserva-
ion of graft fixation, seal, and branch vessel patency, re-
ains to be determined. The ideal candidate and proce-
ural steps for endovascular repair remain to be defined.
himney technique appears to be suited for patients at high
isk for open repair and symptomatic or contained ruptured
neurysms. In case of involvement of more than two aortic
ranches, f-EVAR is preferred.
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